Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: J Immunol. 2018 Jun 1;201(2):583–603. doi: 10.4049/jimmunol.1700958

Fig 15. Effect of inhibition of aspartic CTS in J774.16 cells viability and PMP.

Fig 15

(A–D) PepsA treatment showed a significant increase in the apoptotic population. (E–L) PMP analysis shows an increase in cells with PMP only in the apoptotic population. Shown is representative data from 2 experiments mean and SD. One-way ANOVA with Dunnett’s multiple comparison test *p > 0.0332, **p < 0.0021, ***p < 0.0002 and #p < 0.0001.